Innate Biologics has entered into a collaborative research agreement with The Wistar Institute, an international leader in biomedical research. Innate Biologics is a pioneer in targeting, treating and preventing inflammation and is working with Wistar to develop a first-of-its-kind recombinant protein platform, which specifically targets intracellular inflammatory signaling pathways. Innate Biologics is in the pre-clinical stage of developing novel cosmeceutical and therapeutic approaches for...